Stock Events

Stock Events

Avita Therapeutics 

€2.84
61
-€0.01-0.35%Friday 17:16

Statistics

Day High
2.84
Day Low
2.71
52W High
2.93
52W Low
0.652
Volume
-
Avg. Volume
-
Mkt Cap
87.83M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 5Expected
Q1 2026
Q2 2026
Q3 2026
-0.3
-0.26
-0.22
-0.18
Expected EPS
-0.213224004
Actual EPS
-0.178132

Financials

-68.01%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
62.29MRevenue
-42.37MNet Income

Analyst Ratings

$11.89Average Price Target
The highest estimate is ⁦15.93⁩.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 51K.STU. It's not an investment recommendation.
BetaShares NASDAQ 100
10
NDQ.AU
BHP Group Limited
9
BHP.AU
Tesla
6
TSLA
Woodside Energy Group
6
WDS.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers products in wound care and regenerative medicine, competing in the same space as AVITA's skin regeneration technology.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its subsidiary Ethicon, produces a range of wound closure products, directly competing with AVITA's regenerative medical solutions.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation provides medical devices and equipment that include products for wound management and surgical solutions, overlapping with AVITA's market.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation offers medical devices that are used in various surgical procedures, including those for wound care and tissue repair, competing with AVITA.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but has products in surgical wound management, indirectly competing with AVITA's offerings.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical, Inc. specializes in robotic-assisted surgery, offering innovative solutions that could compete with traditional regenerative treatments offered by AVITA.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie Inc. has a broad portfolio of medical products, including in dermatology and wound healing, which could compete with AVITA's skin regeneration products.
Pfizer
PFE
Mkt Cap173.95B
Pfizer Inc. has investments in regenerative medicine and tissue repair, areas that are directly competitive with AVITA Medical's core business.
Novartis
NVS
Mkt Cap303.67B
Novartis AG engages in the research, development, and marketing of healthcare products, including those in skin health and regeneration, competing with AVITA.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. provides a portfolio of hospital and surgical products, including advanced wound care, which competes with AVITA Medical's regenerative technology.

About

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Show More
CEO
Cary G. Vance
Employees
226
Country
United States
ISIN
AU000000AVH4
WKN
000A2P8DT

Listings

MU
DE
51K.MU
MU
DE
GCR.MU
STU
DE
51KB.STU
MU
DE
51KB.MU

0 Comments

Share your thoughts

FAQs

What is Avita Therapeutics stock price today?▼
The current price of 51K.STU is €2.84 EUR — it has decreased by -0.35% in the past 24 hours. Watch Avita Therapeutics stock price performance more closely on the chart.
What is Avita Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Avita Therapeutics stocks are traded under the ticker 51K.STU.
What is Avita Therapeutics market cap?▼
Today Avita Therapeutics has the market capitalization of 87.83M
When is the next Avita Therapeutics earnings date?▼
Avita Therapeutics is going to release the next earnings report on February 25, 2027.
What were Avita Therapeutics earnings last quarter?▼
51K.STU earnings for the last quarter are -0.18 EUR per share, whereas the estimation was -0.21 EUR resulting in a +16.46% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Avita Therapeutics revenue for the last year?▼
Avita Therapeutics revenue for the last year amounts to 62.29M EUR.
What is Avita Therapeutics net income for the last year?▼
51K.STU net income for the last year is -42.37M EUR.
How many employees does Avita Therapeutics have?▼
As of November 7, 2026, the company has 226 employees.
In which sector is Avita Therapeutics located?▼
Avita Therapeutics operates in the Health & Wellness sector.
When did Avita Therapeutics complete a stock split?▼
The last stock split for Avita Therapeutics was on June 10, 2008 with a ratio of 1:10.
Where is Avita Therapeutics headquartered?▼
Avita Therapeutics is headquartered in VALENCIA, United States.